Bendel Markus A, Moeschler Susan M, Qu Wenchun, Hanley Eugerie, Neuman Stephanie A, Eldrige Jason S, Hoelzer Bryan C
Mayo Clinic, Rochester, MN 55905, USA.
Ozark Orthopaedics, Fayetteville, AR 72703, USA.
Pain Res Treat. 2016;2016:2134959. doi: 10.1155/2016/2134959. Epub 2016 Aug 11.
A recent publication reported the incidence of postdural puncture headache (PDPH) in conjunction with intrathecal drug delivery system (IDDS) implantation to be nearly 23 percent. Many patients responded to conservative measures but a percentage needed invasive treatment with an epidural blood patch (EBP). There is limited data to describe the technical details, success rates, and complications associated with EBP in this population. This study aims to provide a retrospective report of EBP for patients suffering from PDPH related to IDDS implantation. A chart review established a cohort of patients that required EBP in relation to a PDPH after IDDS implantation. This cohort was evaluated for demographic data as well as details of the EBP including technical procedural data, success rates, and complications. All patients received a trial of conservative therapy. Standard sterile technique and skin preparation were utilized with no infectious complications. The EBP was placed below the level of the IDDS catheter in 94% of procedures. Fluoroscopy was utilized in each case. The mean EBP volume was 18.6 cc and median time of EBP was day 7 after implant. There were no complications associated with EBP. EBP appears to be an effective intervention in this subset of PDPH patients.
最近的一份出版物报道,与鞘内药物输送系统(IDDS)植入相关的硬膜穿刺后头痛(PDPH)的发生率接近23%。许多患者对保守治疗有反应,但有一部分患者需要进行硬膜外血贴(EBP)侵入性治疗。关于该人群中EBP的技术细节、成功率和并发症的数据有限。本研究旨在提供一份关于因IDDS植入导致PDPH的患者接受EBP治疗的回顾性报告。通过图表回顾确定了一组在IDDS植入后因PDPH需要EBP的患者。对该队列进行了人口统计学数据以及EBP细节的评估,包括技术操作数据、成功率和并发症。所有患者都接受了保守治疗试验。采用标准无菌技术和皮肤准备,未出现感染并发症。94%的操作中EBP放置在IDDS导管水平以下。每例均使用了荧光透视。EBP的平均体积为18.6立方厘米,EBP的中位时间为植入后第7天。未出现与EBP相关的并发症。EBP似乎是这部分PDPH患者的一种有效干预措施。